Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China

被引:0
|
作者
Ming Shi
机构
关键词
Hepatocellular carcinoma; Transarterial chemoembolization; Palliative treatment; Prognosis;
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
AIM:To identify prognostic factors from pretreatment variables of the initial transarterial chemoembolization(TACE)procedure in unresectable hepatocellular carcinoma(HCC). METHODS:One thousand and five hundred and sixtynine patients with unresectable HCC underwent TACE as initial treatment were retrospectively studied.Pretreatment variables of the initial TACE procedure with a P value less than 0.05 by univariate analysis were subjected to Cox proportional hazards model. RESULTS:The median overall survival time and 1-, 5-,10-year survival rates were 10.37 mo,47%,10%, and 7%,respectively.A Cox proportional hazard model showed that 8 pretreatment factors of regional lymphnodes metastasis,Child-Pugh class,macrovascular invasion,greatest dimension,α-fetoprotein(AFP), Hepatitis virus B,tumor capsule,and nodules were independent prognostic factors.Patients with multimodality therapy have better survival than those with TACE treatment only. CONCLUSION:Tumor status,hepatic function reserve,AFP,and hepatitis virus B status were independent prognostic factors for unresectable HCC.Distant metastasis might not be a contraindication to TACE. Multimodality therapy might improve survival.
引用
收藏
页码:264 / 269
页数:6
相关论文
共 50 条
  • [21] Impact of pre-sarcopenia on outcomes of transarterial chemoembolization in unresectable hepatocellular carcinoma
    Rattanasupar, Attapon
    Prateepchaiboon, Tanaporn
    Akarapatima, Keerati
    Songjamrat, Apiradee
    Pakdeejit, Songklod
    Chang, Arunchai
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [22] A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma
    Gish, Robert G.
    Gordon, Stuart C.
    Nelson, David
    Rustgi, Vinod
    Rios, Israel
    HEPATOLOGY INTERNATIONAL, 2009, 3 (03) : 480 - 489
  • [23] A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma
    Robert G. Gish
    Stuart C. Gordon
    David Nelson
    Vinod Rustgi
    Israel Rios
    Hepatology International, 2009, 3 : 480 - 489
  • [24] Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination
    Ju, Shuguang
    Zhou, Chen
    Hu, Junwen
    Wang, Yingliang
    Wang, Chaoyang
    Liu, Jiacheng
    Yang, Chongtu
    Huang, Songjiang
    Li, Tongqiang
    Chen, Yang
    Bai, Yaowei
    Yao, Wei
    Xiong, Bin
    BMC CANCER, 2022, 22 (01)
  • [25] Clinical Outcomes of Transarterial Chemoembolization Combined with Hypofraction Radiation Therapy for Unresectable Large Hepatocellular Carcinoma
    Shen, Juanjuan
    Zhong, Nanbao
    Chen, Zhonghua
    Ma, Danyun
    Lin, Jianhai
    EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, 2023, 7 (04): : 388 - 395
  • [26] Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination
    Shuguang Ju
    Chen Zhou
    Junwen Hu
    Yingliang Wang
    Chaoyang Wang
    Jiacheng Liu
    Chongtu Yang
    Songjiang Huang
    Tongqiang Li
    Yang Chen
    Yaowei Bai
    Wei Yao
    Bin Xiong
    BMC Cancer, 22
  • [27] Development and Validation of Nomograms to Predict the Prognosis of Patients With Unresectable Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
    Zhao, Dongxu
    Xu, Wei
    Zhan, Yi
    Xu, Lin
    Ding, Wenbin
    Xu, Aibing
    Hou, Zhongheng
    Ni, Caifang
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2023, 17
  • [28] Outcome of transarterial chemoembolization-based multi-modal treatment in patients with unresectable hepatocellular carcinoma
    Song, Do Seon
    Nam, Soon Woo
    Bae, Si Hyun
    Kim, Jin Dong
    Jang, Jeong Won
    Song, Myeong Jun
    Lee, Sung Won
    Kim, Hee Yeon
    Lee, Young Joon
    Chun, Ho Jong
    You, Young Kyoung
    Choi, Jong Young
    Yoon, Seung Kew
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (08) : 2395 - 2404
  • [29] Transarterial chemoembolization and bland embolization for hepatocellular carcinoma
    Tsochatzis, Emmanuel A.
    Fatourou, Evangelia
    O'Beirne, James
    Meyer, Tim
    Burroughs, Andrew K.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (12) : 3069 - 3077
  • [30] Outcome of transarterial chemoembolization-based multi-modal treatment in patients with unresectable hepatocellular carcinoma
    Do Seon Song
    Soon Woo Nam
    Si Hyun Bae
    Jin Dong Kim
    Jeong Won Jang
    Myeong Jun Song
    Sung Won Lee
    Hee Yeon Kim
    Young Joon Lee
    Ho Jong Chun
    Young Kyoung You
    Jong Young Choi
    Seung Kew Yoon
    World Journal of Gastroenterology, 2015, 21 (08) : 2395 - 2404